Evolving Landscape of Multiple Myeloma: Current and Emerging Therapies for Frontline and Early Relapse : Episode 5
Impact of CAR T-cell therapy in Earlier Lines of MM
A panel of experts examines the impact and potential of CAR T-cell therapy in earlier treatment lines for multiple myeloma, evaluating its efficacy, safety.
Video content above is prompted by the following:
- Let’s talk about the use of CAR T-cell therapy in early R/R MM. Please share your thoughts on the following data:
- CARTITUDE-4
- KarMMa-3
- How does the CAR T-cell fit into 2nd line treatment in your practice and in which patients do you use CAR T-cell in?
- How does CAR T-cell therapy in the 2nd line affect your approach to front-line therapy for MM?
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
